PHAR
Price:
$13.34
Market Cap:
$938.08M
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized product is Ruconest, a recombinant human C1 esterase inhibitor utilized for the acute treatment of hereditary angioedema. Pharming's development pipeline also includes rhC1INH, which is being investigated for conditions such as pre-eclampsia, acute kidney injury, and COVID-19. Additionally, the company is developing leniolisib, a phosphoinositide 3-kin...[Read more]
Industry
Biotechnology
IPO Date
2020-12-23
Stock Exchange
NASDAQ
Ticker
PHAR
According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 2.63. This represents a change of -5.80% compared to the average of 2.79 of the last 4 quarters.
The mean historical Current Ratio of Pharming Group N.V. over the last ten years is 2.82. The current 2.63 Current Ratio has changed 9.24% with respect to the historical average. Over the past ten years (40 quarters), PHAR's Current Ratio was at its highest in in the March 2022 quarter at 5.56. The Current Ratio was at its lowest in in the March 2017 quarter at 1.07.
Average
2.82
Median
2.69
Minimum
1.05
Maximum
5.33
Discovering the peaks and valleys of Pharming Group N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 166.40%
Maximum Annual Current Ratio = 5.33
Minimum Annual Increase = -70.80%
Minimum Annual Current Ratio = 1.05
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.59 | -29.05% |
| 2024 | 3.65 | -10.16% |
| 2023 | 4.06 | -12.72% |
| 2022 | 4.65 | -12.84% |
| 2021 | 5.33 | 91.52% |
| 2020 | 2.78 | 166.40% |
| 2019 | 1.05 | -25.20% |
| 2018 | 1.40 | -3.80% |
| 2017 | 1.45 | 20.03% |
| 2016 | 1.21 | -70.80% |
The current Current Ratio of Pharming Group N.V. (PHAR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.43
5-year avg
4.05
10-year avg
2.82
Pharming Group N.V.’s Current Ratio is less than Tango Therapeutics, Inc. (27.38), less than Septerna Inc (4.71), less than Arbutus Biopharma Corp (54.26), greater than Fortrea Holdings Inc. (0.95), less than ProKidney Corp. (9.06), less than Bicara Therapeutics Inc. Common Stock (13.85), less than Palvella Therapeutics, Inc. (28.88), less than Mind Medicine (MindMed) Inc. (4.69), less than Kura Oncology, Inc. (6.15), less than EyePoint Pharmaceuticals, Inc. (6.66),
| Company | Current Ratio | Market cap |
|---|---|---|
| 27.38 | $3.92B | |
| 4.71 | $1.68B | |
| 54.26 | $904.72M | |
| 0.95 | $1.67B | |
| 9.06 | $615.34M | |
| 13.85 | $1.47B | |
| 28.88 | $1.75B | |
| 4.69 | $1.56B | |
| 6.15 | $967.64M | |
| 6.66 | $1.15B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Pharming Group N.V.'s Current Ratio?
How is the Current Ratio calculated for Pharming Group N.V. (PHAR)?
What is the highest Current Ratio for Pharming Group N.V. (PHAR)?
What is the 3-year average Current Ratio for Pharming Group N.V. (PHAR)?
What is the 5-year average Current Ratio for Pharming Group N.V. (PHAR)?
How does the current Current Ratio for Pharming Group N.V. (PHAR) compare to its historical average?